Clinigene International Limited
Clinigene is a fully owned subsidiary of Syngene International Ltd., one of Asia’s largest drug discovery and development CROs. With a US FDA and EMA inspected phase-1 clinic, GLP compliant immunoassay lab, CAP and NABL accredited central lab and a large team of experienced clinical research professionals, Clinigene provides a complete range of clinical development solutions (Phase I-IV, and BA/BE) across a wide range of therapeutic areas.
Apart from clinical development of novel drugs and biosimilars, our experience encompasses conducting bioequivalence studies on generic drugs and providing a comprehensive range of laboratory services including PK and immunogenicity analysis for non-clinical and clinical samples.
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters